Hemex Health develops the Gazelle® diagnostic device, a portable platform that utilizes cellulose acetate electrophoresis for the rapid detection of hemoglobin disorders such as sickle cell disease and beta-thalassemia. This device enables front-line healthcare workers to provide accurate and affordable testing in remote settings, facilitating timely medical treatment for at-risk populations.
Funding
$12.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Millions worldwide are at risk of inheriting hemoglobin disorders like sickle cell disease and beta-thalassemia, but access to rapid, accurate diagnostic testing at the point of care remains limited, especially in resource-constrained settings. Delayed diagnosis contributes to preventable child deaths and hinders timely medical intervention.
Solution
Hemex Health's Gazelle® is a portable, point-of-care diagnostic platform that enables rapid and affordable detection of hemoglobin disorders. Utilizing a miniaturized version of cellulose acetate electrophoresis, the Gazelle® Hb Variant test identifies hemoglobin disorders in just 8 minutes, displaying hemoglobin percentages by type. Designed for use by front-line healthcare workers with minimal training, the device facilitates accurate testing in remote and challenging environments, empowering timely treatment for at-risk populations. The Gazelle® platform also supports the Gazelle™ Ferritin Test, an easy-to-use assay for measuring ferritin levels using whole blood, serum, or plasma.
Target Audience
The primary target audience includes front-line healthcare workers and providers in remote or resource-limited settings who need rapid, accurate, and affordable diagnostic tools for hemoglobin disorders and ferritin levels.
Features
- Portable, battery-powered design for point-of-care testing in any environment
- Miniaturized cellulose acetate electrophoresis technology for rapid hemoglobin analysis
- Results displayed in 8 minutes, including hemoglobin percentages by type
- Minimal training required for test administration
- Data storage locally or transmission to the Cloud for patient and disease tracking
- Gazelle™ Ferritin Test for measuring ferritin levels using whole blood, serum, or plasma (coming soon)